Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 2/20 | 0.38 |
| ▸ | CDC25A | P30304 | 1/20 | 0.36 |
| ▸ | CDC25B | P30305 | 1/20 | 0.36 |
| ▸ | CDC25C | P30307 | 1/20 | 0.36 |
| ▸ | PRKCA | P17252 | 9/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16666210 | 1.00 | EPHX2 (0.38) | EPHX2CDC25ACDC25BCDC25CPRKCA | |
| SCHEMBL322644 | 1.00 | EPHX2 (0.38) | EPHX2CDC25ACDC25BCDC25CPRKCA | |
| SCHEMBL16666208 | 1.00 | EPHX2 (0.38) | EPHX2CDC25ACDC25BCDC25CPRKCA | |
| SCHEMBL9848775 | 0.94 | EPHX2 (0.39) | EPHX2CDC25ACDC25BCDC25CPRKCA | |
| SCHEMBL29540037 | 0.94 | EPHX2 (0.39) | EPHX2CDC25ACDC25BCDC25CPRKCA | |
| SCHEMBL9414401 | 0.94 | EPHX2 (0.39) | EPHX2CDC25ACDC25BCDC25CPRKCA | |
| SCHEMBL9848776 | 0.94 | EPHX2 (0.39) | EPHX2CDC25ACDC25BCDC25CPRKCA | |
| SCHEMBL9414404 | 0.94 | EPHX2 (0.39) | EPHX2CDC25ACDC25BCDC25CPRKCA | |
| SCHEMBL10491968 | 0.92 | PRKCA (0.35) | PRKCA | |
| SCHEMBL10492039 | 0.92 | PRKCA (0.35) | PRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 296 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12624313-B2 | Suspending polymer composition, and method of use thereof | ISP INVESTMENTS LLC (US) | 2026-05-12 | — | — | US | disclosed |
| US-20260108624-A1 | METHODS AND COMPOSITIONS FOR TRANSPORT, STORAGE, AND DELIVERY OF NUCLEIC ACIDS AND OTHER MOLECULES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2026-04-23 | — | — | US | disclosed |
| EP-4340807-B1 | HAIR COLOR COMPOSITIONS FOR MITIGATING COLOR LOSS | LUBRIZOL ADVANCED MAT INC (US) | 2026-01-28 | — | — | EP | disclosed |
| US-12527733-B2 | Fragrance compositions | ELC MANAGEMENT LLC (US) | 2026-01-20 | — | — | US | disclosed |
| EP-4413055-B1 | STABILIZED RHEOLOGY MODIFIER EMULSIONS | LUBRIZOL ADVANCED MAT INC (US) | 2025-12-03 | — | — | EP | disclosed |
| US-12472244-B2 | Immunogenic compositions and uses thereof | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-11-18 | — | — | US | disclosed |
| US-12440550-B2 | Immunogenic compositions and uses thereof | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-10-14 | — | — | US | disclosed |
| US-20250312436-A1 | STABILIZATION OF VIRUS-BASED THERAPEUTIC AGENT | ELAREX INC. (CA) | 2025-10-09 | — | — | US | disclosed |
| WO-2025085892-A2 | SULFATE-FREE PERSONAL CARE COMPOSITIONS | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2025-04-24 | — | — | WO | disclosed |
| US-20250059426-A1 | ORGANIC HEAT TRANSFER SYSTEM, METHOD AND FLUID | THE LUBRIZOL CORPORATION (US) | 2025-02-20 | — | — | US | disclosed |
| EP-1303260-A2 | LINKAGE OF AGENTS USING MICROPARTICLES | Pericor Science, Inc. (US) | 2003-04-23 | — | — | EP | disclosed |
| EP-1203141-A1 | LINKAGE OF AGENTS TO TISSUE | Pericor Science, Inc. (US) | 2002-05-08 | — | — | EP | disclosed |
| EP-1202706-A1 | LYSINE OXIDASE LINKAGE OF AGENTS TO TISSUE | Pericor Science, Inc. (US) | 2002-05-08 | — | — | EP | disclosed |
| WO-2002007707-A2 | LINKAGE OF AGENTS USING MICROPARTICLES | PERICOR SCIENCE, INC. (US) | 2002-01-31 | — | — | WO | disclosed |
| WO-2001007009-A1 | LYSINE OXIDASE LINKAGE OF AGENTS TO TISSUE | PERICOR SCIENCE, INC. (US) | 2001-02-01 | — | — | WO | disclosed |
| WO-2001006829-A2 | LINKAGE OF AGENTS TO TISSUE | PERICOR SCIENCE, INC. (US) | 2001-02-01 | — | — | WO | disclosed |
| EP-1011609-A4 | COMPOSITIONS FOR COSMETIC APPLICATIONS | MEDLOGIC GLOBAL CORP (US) | 2000-08-16 | — | — | EP | disclosed |
| EP-1011609-A1 | COMPOSITIONS FOR COSMETIC APPLICATIONS | MedLogic Global Corporation (US) | 2000-06-28 | — | — | EP | disclosed |
| WO-1998050005-A1 | COMPOSITIONS FOR COSMETIC APPLICATIONS | MEDLOGIC GLOBAL CORPORATION (US) | 1998-11-12 | — | — | WO | disclosed |
| US-5091100-A | Fatty triglyceride-in-water solid film high temperature prelube emulsion for hot rolled steel | NALCO CHEMICAL COMPANY (US) | 1992-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260108624-A1 | METHODS AND COMPOSITIONS FOR TRANSPORT, STORAGE, AND DELIVERY OF NUCLEIC ACIDS AND OTHER MOLECULES | SLC2A9, SLC2A2, TRMT1 | EPHX2 4366/4885CDC25A 3826/4885CDC25B 3853/4885 |
| US-12527733-B2 | Fragrance compositions | CUTA, IL36G, TAS2R40 | EPHX2 1426/4885CDC25A 4081/4885CDC25B 4212/4885 |
| US-12624313-B2 | Suspending polymer composition, and method of use thereof | MUC1, ALG1, CHD1 | EPHX2 1520/4885CDC25A 3511/4885CDC25B 4305/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.